Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)

China flag China · Delayed Price · Currency is CNY
5.56
+0.02 (0.36%)
Apr 30, 2026, 3:14 PM CST
9.02%
Market Cap 3.24B
Revenue (ttm) 747.80M
Net Income (ttm) 54.99M
Shares Out 583.03M
EPS (ttm) 0.09
PE Ratio 63.36
Forward PE n/a
Dividend 0.01 (0.22%)
Ex-Dividend Date Jun 17, 2025
Volume 8,826,600
Average Volume 11,711,164
Open 5.32
Previous Close 5.54
Day's Range 5.32 - 5.61
52-Week Range 5.09 - 6.82
Beta 0.25
RSI 52.37
Earnings Date Aug 28, 2026

About SHE:300239

Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen and their derivative products in the People’s Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private label collagen and unflavored collagen jars. The company also provides organic fertilizers, water soluble fertilizers, and compound microbial fertilizers... [Read more]

Sector Healthcare
Founded 1960
Employees 1,424
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300239
Full Company Profile

Financial Performance

In 2025, SHE:300239's revenue was 745.31 million, a decrease of -15.78% compared to the previous year's 884.93 million. Earnings were 54.34 million, a decrease of -36.80%.

Financial Statements

News

There is no news available yet.